Smart wearable patch systems that combine biosensing and therapeutic components have
emerged as promising approaches for personalized healthcare and therapeutic platforms …

Simple Summary Direct-acting oral anticoagulants are becoming popular therapeutic option
in patients with cancer. We investigated the available literature in order to try to sum up the …

Background and Objectives: Previous studies regarding tranexamic acid (TXA) in total knee
arthroplasty (TKA) investigated only symptomatic deep vein thrombosis (DVT), or did not …

Purpose Pulmonary embolism (PE) is a significant contributor to mortality in patients with
cancer. Although anticoagulation serves as the cornerstone of treatment for cancer …

Many factors contribute to mortality in lung cancer, including the presence of concomitant
cardiovascular disease. In the treatment of early stage of lung cancer, the presence of …

Cancer is a leading cause of death. Venous thromboembolism (VTE) is an often-overlooked
cause of morbidity and mortality in cancer patients that can be readily prevented and treated …

Background Acute pulmonary embolism (PE) can occur as a manifestation of an underlying
cancer and be of paraneoplastic aetiology. A previously unknown cancer is sometimes …

Purpose Central nervous system (CNS) malignant neoplasms may lead to venous
thromboembolism (VTE) and bleeding, which result in rehospitalization, morbidity and …

Introduction We performed a quality assessment and comparison of clinical practice
guidelines (CPGs) for the prevention and treatment of venous thromboembolism (VTE) in …

(1) Background and Objectives: Venous thromboembolism (VTE) is strongly associated with
cancer, and may be the first event revealing occult neoplasia. Nonetheless, the reasonable …